sales@nebiolab.com Email Your Inquiry
(203) 361 3780 Speak to Our Scientists
NorthEast BioLab Agile Bioanalysis Services CRO
  • Expertise
    • All Expertise
    • Liquid Chromatography Mass Spectrometry
      • HPLC Method Development Validation
      • Mass Spectrometric Analysis
    • ELISA Method
      • Luminex Multiplex Assay
    • Meso Scale Discovery Assay
    • LI-COR Odyssey Assay
    • Method Development, Validation, and Transfer
      • Method Validation
      • Method Development
      • Method Transfer
  • Services
    • All Services
    • Pharmacokinetics (PK) Study
      • Toxicology (Tox) Study
      • Bioequivalence and Bioavailability Studies
      • PK PD Analysis
      • Dose Formulation Analysis
      • Drug Metabolism and Pharmacokinetics (DMPK)
      • ADME Studies
    • ADA Assay Immunogenicity Testing
    • Biomarker Testing Services
      • Biomarker Assay List
    • Bioanalytical Assay
      • Biochemical Assay
      • Mechanism of Action (MOA) Studies
      • Cell-based Assays
      • Cytotoxicity Assay
  • Solutions
    • All Solutions
    • Bioanalysis
    • GLP Laboratory
    • Clinical CRO
      • Clinical Trial Sample Management and Storage
    • Preclinical CRO
    • Analytical Testing
      • Analytical Quantitation
    • Non-GLP Testing
      • Discovery and Research
      • Cosmetic Testing
  • About Us
    • About Us
    • Overview
    • Why Us?
    • Values
    • Leadership
    • Process
    • Quality and Compliance
    • Facility and Equipment
    • Therapeutic Areas
    • Partners
    • Careers
      • GLP Quality Assurance Manager, Bioanalytical Lab
      • Sr. Scientist, ELISA Immunoassay Bioanalysis
      • Sr. Scientist, LC-MS/MS Bioanalysis – Hamden, CT, USA
      • Associate Scientist, Central Laboratory Services
      • Sr. Scientist – Pharmacokinetics (PK) Studies
      • Content Manager, Scientific and Regulatory Writing
  • Resources
    • Learning Center
    • Blog
    • Case Study
    • News and Events
    • Testimonials
    • Contact Us
  • Request Quote
NorthEast Biolab Agile Bioanalysis Services CRO Request Quote

Expertise

  • All Expertise
    • Liquid Chromatography Mass Spectrometry
      • HPLC Method Development Validation
      • Mass Spectrometric Analysis
    • ELISA Method
      • Luminex Multiplex Assay
    • Meso Scale Discovery Assay
      • LI-COR Odyssey Assay
        • Method Development, Validation, and Transfer
          • Method Validation
          • Method Development
          • Method Transfer

        Services

        • All Services
          • Pharmacokinetics (PK) Study
            • Toxicology (Tox) Study
            • Bioequivalence and Bioavailability Studies
            • PK PD Analysis
            • Dose Formulation Analysis
            • Drug Metabolism and Pharmacokinetics (DMPK)
            • ADME Studies
          • ADA Assay Immunogenicity Testing
            • Biomarker Testing Services
              • Biomarker Assay List
            • Bioanalytical Assay
              • Biochemical Assay
              • Mechanism of Action (MOA) Studies
              • Cell-based Assays
              • Cytotoxicity Assay

            Solutions

            • All Solutions
              • Bioanalysis
                • GLP Laboratory
                  • Clinical CRO
                    • Clinical Trial Sample Management and Storage
                  • Preclinical CRO
                    • Analytical Testing
                      • Analytical Quantitation
                    • Non-GLP Testing
                      • Discovery and Research
                      • Cosmetic Testing

                    About Us

                    • About Us
                      • Overview
                        • Why Us?
                          • Values
                            • Leadership
                              • Process
                                • Quality and Compliance
                                  • Facility and Equipment
                                    • Therapeutic Areas
                                      • Partners
                                        • Careers
                                          • GLP Quality Assurance Manager, Bioanalytical Lab
                                          • Sr. Scientist, ELISA Immunoassay Bioanalysis
                                          • Sr. Scientist, LC-MS/MS Bioanalysis – Hamden, CT, USA
                                          • Associate Scientist, Central Laboratory Services
                                          • Sr. Scientist - Pharmacokinetics (PK) Studies
                                          • Content Manager, Scientific and Regulatory Writing

                                        Resources

                                        • Learning Center
                                          • Blog
                                            • Case Study
                                              • News and Events
                                                • Testimonials
                                                  • Contact Us

                                                    Request Quote

                                                      Contact Us

                                                      • Home
                                                      • mAb Fab Immunoassay Development, GLP Validation, And Sample Analysis

                                                      Monoclonal Antibody Fragment PK ELISA Immunoassay Development, GLP Validation, And Sample Analysis

                                                      By Abhay Pandey, MBA
                                                      Reading Time: 3 minutes

                                                      Challenge

                                                      One of our sponsors requested immunoassay development and validation to measure a humanized therapeutic monoclonal antibody (mAb) fragment (Fab) that inhibits a human growth factor involved in the pathogenesis of a common degenerative disease of aging.

                                                      Antibody fragments offer numerous advantages over full-length antibodies in terms of production cost, increased penetration into the target tissue, and reduced potential for inappropriate activation of immune effector mechanisms. However, because antibody fragments lack many common domains typically targeted (e.g., Fc regions) by immunoassay reagents for binding and detection, they may also present unique challenges for bioassay design, potentially impacting sensitivity since fewer antigens/antibodies can bind to each fragment.

                                                      We could try to optimize the concentration of coating and detection reagents to improve sensitivity, but this strategy carries the risk of increasing background noise due to specific and nonspecific interactions within the various assay components (e.g., the therapeutic molecule, the blocking agents, and/or the coating antigen). The potential for off-target specific interactions is especially concerning when the matrix belongs to a closely related species, in this case a non-human primate.

                                                      Solution

                                                      In this case, our team leveraged their decades of collective experience in immunoassay development and troubleshooting to explore multiple assay configurations.

                                                      Ultimately, a robust and reproducible indirect ELISA using the antigen target of the monoclonal antibody fragment for capture and a secondary antibody against the mAb’s Fab fragment for detection was determined as the best approach to assay this therapeutic. Since only a portion of the mAb was detected, increased background noise proved challenging.

                                                      Thus, a checkerboard approach was used to determine the optimal concentrations for coating and detection antibodies. Additionally, our veteran team fine-tuned multiple aspects of the initial immunoassay, including a novel approach with preincubation of the detection antibody with a small percentage of a homologous matrix. This approach tremendously aided the immunoassay development, GLP validation, and subsequent sample analysis by enhancing signal-to-noise and boosting sensitivity.

                                                      Outcome

                                                      An immunoassay that met the sponsor-mandated sensitivity and specificity requirements was successfully developed and validated as per the FDA bioanalytical guidelines, and bioanalysis of the mAb was completed in plasma and ocular fluid matrices for GLP PK study in NHPs.

                                                      Over the last decade, mAbs, already well known for their use in immunodetection-based assays, have also found their place as a therapeutic agent for treating various diseases. To either provide a differentiated therapeutic advantage or overcome the side effects, modified mAbs are increasingly being developed and put forward for FDA authorization. Therefore, novel approaches to assay these therapeutics that build on traditional immunoassay methods are of high value to facilitate regulatory approval.

                                                      Registered And Inspected By Various Regulatory Agencies

                                                      • Good Laboratory Practice for Nonclinical Laboratory Studies
                                                      • Food and Drug Administration (FDA)

                                                      Speak To Our Scientist About Your Monoclonal Antibody (mAb) PK ELISA Immunoassay Development And GLP Validation

                                                      NorthEast BioLab Are Ready to Help!
                                                      Call Us Today

                                                      Similar Case Study Articles

                                                      • LC-MS/MS Method Development And GLP Validation For Quantitating Amino Acids In Human Plasma

                                                      • Cytokine Multiplex Analysis And Qualification Using Meso Scale Discovery Immunoassays

                                                      • Oligonucleotide Hybrid MSD ELISA PK Immunoassay Development And GLP Validation

                                                      • LC MS Method Development And GLP Validation For PK Plasma Sample Analysis

                                                      • Incurred Sample Reanalysis (ISR): Definition, FDA Requirements, And Study Evaluation

                                                      • Dried Blood Spot (DBS) Analysis: Advantages And Challenges

                                                      Explore Our Expertise

                                                      What NorthEast BioLab Can Do For You
                                                      • Liquid Chromatography Mass Spectrometry

                                                      • ELISA Method

                                                      • Meso Scale Discovery Assay

                                                      • Luminex Multiplex Assay

                                                      • LI-COR Odyssey Assay

                                                      • PK PD Analysis

                                                      • Method Development Validation and Transfer

                                                      • Liquid Chromatography Mass Spectrometry

                                                      • ELISA Method

                                                      • Meso Scale Discovery Assay

                                                      • Luminex Multiplex Assay

                                                      • LI-COR Odyssey Assay

                                                      • PK PD Analysis

                                                      • Method Development Validation and Transfer

                                                      Expertise

                                                      • Liquid Chromatography Mass Spectrometry
                                                      • ELISA Method
                                                      • Meso Scale Discovery Assay
                                                      • LI-COR Odyssey Assay
                                                      • Method Development Validation and Transfer

                                                      Services

                                                      • Pharmacokinetics (PK) Study
                                                      • ADA Assay Immunogenicity Testing
                                                      • Biomarker Testing Services
                                                      • Bioanalytical Assay

                                                      Solutions

                                                      • Bioanalysis
                                                      • GLP Laboratory
                                                      • Clinical CRO
                                                      • Preclinical CRO
                                                      • Analytical Testing
                                                      • Non-GLP Testing

                                                      About Us

                                                      • Overview
                                                      • Why Us?
                                                      • Values
                                                      • Leadership
                                                      • Process
                                                      • Quality and Compliance
                                                      • Facility and Equipment
                                                      • Therapeutic Areas
                                                      • Partners
                                                      • Careers

                                                      Resources

                                                      • Learning Center
                                                      • Blog
                                                      • Case Study
                                                      • News and Events
                                                      • Testimonials
                                                      • Contact Us
                                                      NorthEast BioLab Logo

                                                      35 Worth Ave, Hamden, CT 06518

                                                      sales@nebiolab.com
                                                      (203) 361 3780

                                                      Consult with a Scientist Now

                                                      We Will Contact You Within 1 Business Day

                                                      • Good Laboratory Practice for Nonclinical Laboratory Studies
                                                      • Food and Drug Administration (FDA)
                                                      • United States Drug Enforcement Administration
                                                      • Connecticut State Department of Consumer Protection
                                                      • Privacy Policy
                                                      • Terms of Use
                                                      • Sitemap
                                                      © 2019 - 2025, NorthEast BioAnalytical Laboratories LLC. All rights reserved.

                                                      How Can We Help?

                                                      I agree to receive emails, calls, and messages, etc from NorthEast BioLab.

                                                      Before you go! Get
                                                      your FREE Download:

                                                      Top 7 Hidden Pitfalls to your Bioanalytical Milestones

                                                      Step by step guide on how to accelerate your drug approval

                                                      • Addressing Main Constraints
                                                      • Research Best Practices
                                                      • The Economic Advantage
                                                      • Critical Decision Marketing Mode Easy
                                                      • Legal Documentation Checklist
                                                      We won’t share your email, ever, See our privacy policy

                                                      No thanks, I don’t need to improve my drug approval process